Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  TEL AVIV STOCK EXCHANGE  >  Teva Pharmaceutical Industries Limited    TEVA   IL0006290147

TEVA PHARMACEUTICAL INDUSTRIES LIMITED

(TEVA)
  Report  
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Tel Aviv Stock Exchange
08/08/2019 08/12/2019 08/13/2019 08/14/2019 08/15/2019 Date
2471(c) 2496(c) 2550(c) 2332(c) 2180(c) Last
3 750 929 1 354 827 1 352 529 1 642 446 2 317 398 Volume
+7.90% +1.01% +2.16% -8.55% -6.52% Change
More quotes
Financials (USD)
Sales 2019 17 165 M
EBIT 2019 4 023 M
Net income 2019 -62,8 M
Debt 2019 25 439 M
Yield 2019 -
Sales 2020 17 067 M
EBIT 2020 4 192 M
Net income 2020 1 911 M
Debt 2020 22 640 M
Yield 2020 -
P/E ratio 2019 -
P/E ratio 2020 -
EV / Sales2019 1,60x
EV / Sales2020 1,44x
Capitalization 1 979 M
More Financials
Company
Teva Pharmaceutical Industries Limited is a pharmaceutical company. The Company is engaged in developing, producing and marketing generic medicines and a portfolio of specialty medicines. The Company operates through two segments: Generic medicines and Specialty medicines. The Company develops,... 
Sector
Pharmaceuticals
Calendar
-
More about the company
Surperformance© ratings of Teva Pharmaceutical Indust
Trading Rating : Investor Rating :
More Ratings
Latest news on TEVA PHARMACEUTICAL INDUST
08/16TEVA 96 HOUR DEADLINE ALERT : Approximately 96 Hours Remain; Former Louisiana At..
BU
08/07Patient groups push back against Gilead's pricey HIV prevention treatment
RE
08/07ADR Shares End Higher; Teva Pharmaceutical, Commerzbank Trade Actively
DJ
08/07TEVA PHARMACEUTICAL INDUSTRIES : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCI..
AQ
08/07TEVA PHARMACEUTICAL INDUSTRIES : Seeks New CFO As It Faces High Debt Levels, Opi..
DJ
08/07TEVA PHARMACEUTICAL INDUSTRIES : Finance Chief Michael McClellan to Step Down
DJ
08/07TEVA PHARMACEUTICAL INDUSTRIES LTD : Change in Directors or Principal Officers (..
AQ
08/07TEVA PHARMACEUTICAL INDUSTRIES : Announces CFO Leadership Transition
BU
08/07TEVA PHARMACEUTICAL INDUSTRIES LTD : Results of Operations and Financial Conditi..
AQ
08/07TEVA PHARMACEUTICAL INDUSTRIES : Reports Second Quarter 2019 Financial Results
BU
More news
Analyst Recommendations on TEVA PHARMACEUTICAL INDUST
More recommendations
Sector news : Pharmaceuticals - NEC
08/16ABBVIE : Gets FDA OK for Rheumatoid Arthritis Drug Rinvoq
DJ
08/16CELGENE : FDA Grants Approval to Celgene's Impact for Bone Marrow Disorder Treat..
DJ
08/16ALLERGAN : Form 8.3 - Allergan Plc
DJ
08/16NOVO NORDISK : contests Danish lawsuit claiming $1.75 billion
RE
08/16Correction to AstraZeneca's Lynparza Clinical Trial Article on Wednesday
DJ
More sector news : Pharmaceuticals - NEC
Chart TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Duration : Period :
Teva Pharmaceutical Industries Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends TEVA PHARMACEUTICAL INDUST
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
 
Mean consensus -
Number of Analysts
Average target price
Last Close Price 6,17  $
Spread / Highest target -
Spread / Average Target -
Spread / Lowest Target -
EPS Revisions
Managers
NameTitle
Kåre Schultz President, Chief Executive Officer & Director
Sol J. Barer Chairman
Carlo de Notaristefani Executive Vice President-Global Operations
Michael McClellan Chief Financial Officer & Executive Vice President
Amir Elstein Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
TEVA PHARMACEUTICAL INDUSTRIES LIMITED-62.83%6 726
JOHNSON & JOHNSON1.15%344 517
ROCHE HOLDING LTD.12.24%235 575
ROCHE HOLDING13.20%235 575
MERCK AND COMPANY11.32%213 689
NOVARTIS17.81%202 958